Loading chat...
TN HB1968
Bill
Status
1/22/2026
Primary Sponsor
Andrew Farmer
Click for details
AI Summary
-
Adds three pharmaceutical companies—Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc.—to existing opioid-related statutory provisions alongside Purdue Pharma L.P.
-
Amends Tennessee Code Section 20-13-203, which governs civil litigation procedures related to opioid manufacturers
-
Amends Tennessee Code Section 33-11-103(p), which pertains to mental health and substance abuse services funding or administration
-
Takes effect immediately upon becoming law due to public welfare designation
-
Includes a severability clause ensuring remaining provisions remain valid if any portion is struck down
Legislative Description
AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.
Opioids
Last Action
Assigned to s/c Finance, Ways, and Means Subcommittee
3/11/2026